Fulfilling the promise of biotechnology for India
Despite the immense potential, a lot still needs to be put in place to turn India into a biotechnology hub says James C Greenwood,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Compulsory licensing for anti-cancer drugs: concerns and future ahead
Rai S Mittal, Partner, Titus & Co, Advocates, opines that the recent recommendation for compulsory licensing by the Government…
#Socialmedia: Trending in Indian pharma
The increasing number of net-savvy patients and smartphone-hooked doctors in India has resulted in various social media…
‘The next 3-5 years would see stem cell banking penetration rise above 1 per cent’
Mayur Abhaya, Managing Director and Chief Executive Officer, LifeCell International reveals more in an interview with Shalini…
Evolva in collaboration with Ajinomoto
Ajinomoto will be funding research and development activities at Evolva
Aurobindo Pharma receives two final approvals
The approvals are for felodipine ER and oxacillin injection
IPM sees lowest growth rate in December 2012
For the first time ever, the diabetes market has grown lower than the cardiac market